Develops programmable mRNA-based therapeutics for precise, targeted, and controlled treatment of unmet medical needs.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Radar Therapeutics is a biotech company developing programmable precision therapeutics. Leveraging innovative mRNA technology and proprietary regulatory control elements, the company aims to revolutionize medicine by enabling targeted, timely, and controlled therapeutic interventions. Radar is committed to advancing the boundaries of genetic medicine to address unmet medical needs and improve patient access.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Radar Therapeutics Management Team
Investors
BEV Capital
Eli Lilly and Company
KdT Ventures
NfX Bio
PearVC
Radar Therapeutics Valuations & Financials
View real-time NPM data on Radar Therapeutics stock including daily Radar Therapeutics stock price estimates, valuation history, and historical share price information. Access Radar Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Radar Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Radar Therapeutics? Get in touch to learn more.
Similar Companies
like Radar Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
HiveWatch
Cybersecurity
A cloud-based security platform that unifies existing systems to improve incident response and operational efficiency for physical security teams.
YellowBird
Connects businesses with certified safety professionals for incident investigations, audits, training, and on-site safety management.
Kortuc
Healthcare & Life Sciences
Develops a hydrogen peroxide-based radiosensitizer to enhance tumor radiosensitivity, aiming to improve cancer radiotherapy efficacy.
TeraSpatial
AI & Machine Learning
Solving how AI systems connect by combining RF silicon and embedded AI to boost wireless data throughput under complex conditions.
Speak
Consumer
Generates verbal practice and instant feedback via AI-driven conversation simulations.
Inscope
AI & Machine Learning
Automates GAAP-compliant financial reporting, enhancing accuracy and efficiency for accounting teams.
Collov
AI & Machine Learning
Provides AI-powered virtual staging and design solutions, transforming property photos into photorealistic interiors to enhance listings and sales.
Manus Bio
Healthcare & Life Sciences
Delivers complex natural ingredients through engineered fermentation and large-scale production for replacing conventionally sourced molecules.
FAQ
We have answers
Radar Therapeutics stock does not trade on public stock exchanges. Radar Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Radar Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Radar Therapeutics Stock does not trade on public stock exchanges. In order to sell Radar Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Radar Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Radar Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Radar Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Radar Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Radar Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Radar Therapeutics is a private company and has not had an IPO. There is currently no Radar Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Radar Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
